Difference between revisions of "HCG11"

From LncRNAWiki
Jump to: navigation, search
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
 
==Annotated Information==
 
==Annotated Information==
 
===Approved Symbol===
 
===Approved Symbol===
HCG11
+
HCG11 (HLA complex group 11 (non-protein coding))
===Approved Name===
 
HLA complex group 11 (non-protein coding)
 
===Previous Symbols===
 
_
 
 
===Synonyms===
 
===Synonyms===
 
"bK14H9.3, FLJ14049, FLJ30357"
 
"bK14H9.3, FLJ14049, FLJ30357"
 +
[[File:lncRNA HCG11 was downregulated in prostate cancer.jpg|right|thumb|400px|'''lncRNA HCG11 was downregulated in prostate cancer. '''<ref name="ref1" />]]
 +
[[File:GO and KEGG pathway analysis of HCG11.jpg|right|thumb|400px|'''GO and KEGG pathway analysis of HCG11. '''<ref name="ref1" />]]
 
===Chromosome===
 
===Chromosome===
 
6p22.2
 
6p22.2
 
===RefSeq ID===
 
===RefSeq ID===
 
NR_026790
 
NR_026790
===OMIM ID===
 
_
 
===RefSeq(supplied by NCBI)===
 
NR_026790
 
===pubmed IDs===
 
27522256
 
 
===Disease===
 
===Disease===
 
prostate cancer
 
prostate cancer
 +
===Expression===
 +
{| class='wikitable' style="text-align:center"
 +
|-
 +
! | Experiment
 +
! | Forward primer
 +
! | Reverse primer
 +
|-
 +
| rowspan="1"|qPCR
 +
| | 5′-AGGAGTGGTTGCATTTGGGA-3′
 +
| | 5′-CCCACCACGCAGTGAATAGT-3′<ref name="ref1" />
 +
|}
 +
HCG11 is significantly higher in ovary,breast,thyroid and prostate. TCGA analysis reveals that the expression of HCG11 is significantly suppressed in prostate cancers compared with adjacent normal tissues <ref name="ref1" />
 +
===Function===
 +
Downregulation of HCG11 predicts a poor prognosis in prostate cancer. <ref name="ref1" />
 +
HCG11 has the ability in the regulation of signal transduction, transcription, cell adhesion, and development.<ref name="ref1" />
 +
==Labs working on this lncRNA==
 +
* State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, 200433, People's Republic of China.<ref name="ref1" />
 +
* Center of Translational Medicine, Central Hospital of Zibo, Zibo, 255036, People's Republic of China.<ref name="ref1" />
 +
* Center of Translational Medicine, Central Hospital of Zibo, Zibo, 255036, People's Republic of China. <ref name="ref1" />
 +
* State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, 200433, People's Republic of China.<ref name="ref1" />
 +
==References==
 +
<references>
 +
<ref name="ref1"> Zhang, Y., et al., Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer. Biomed Pharmacother, 2016. 83: p. 936-941.
 +
</ref>(1)
 +
</references>

Latest revision as of 15:46, 27 October 2017

Annotated Information

Approved Symbol

HCG11 (HLA complex group 11 (non-protein coding))

Synonyms

"bK14H9.3, FLJ14049, FLJ30357"

lncRNA HCG11 was downregulated in prostate cancer. [1]
GO and KEGG pathway analysis of HCG11. [1]

Chromosome

6p22.2

RefSeq ID

NR_026790

Disease

prostate cancer

Expression

Experiment Forward primer Reverse primer
qPCR 5′-AGGAGTGGTTGCATTTGGGA-3′ 5′-CCCACCACGCAGTGAATAGT-3′[1]

HCG11 is significantly higher in ovary,breast,thyroid and prostate. TCGA analysis reveals that the expression of HCG11 is significantly suppressed in prostate cancers compared with adjacent normal tissues [1]

Function

Downregulation of HCG11 predicts a poor prognosis in prostate cancer. [1] HCG11 has the ability in the regulation of signal transduction, transcription, cell adhesion, and development.[1]

Labs working on this lncRNA

  • State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, 200433, People's Republic of China.[1]
  • Center of Translational Medicine, Central Hospital of Zibo, Zibo, 255036, People's Republic of China.[1]
  • Center of Translational Medicine, Central Hospital of Zibo, Zibo, 255036, People's Republic of China. [1]
  • State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, 200433, People's Republic of China.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 Zhang, Y., et al., Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer. Biomed Pharmacother, 2016. 83: p. 936-941.